14
PATH3311 Biotherapeutics and Regenerative Medicine TRIM: F31940 Unit ID: 975 Active Unit: Unit Information Resp. Org. Entity: Pathology and Laboratory Medicine (00830) Level: 3 2012 Title: Biotherapeutics and Regenerative Medicine Type: Undergraduate in major(s); Faculty: Medicine, Dentistry and Health Sciences Prerequisites: PATH3303 Advanced Pathology and Laboratory Medicine OR Biomedical Science major level 2 units Corequisites: PATH3354 Immunology and Immunopathology is recommended Incompatibilities: Nil. Unit rules Academic information Unit Content: This unit provides an understanding of biological processes and mechanisms during regeneration and repair and concepts of how they can be used and manipulated for the development of therapeutic strategies in a range of human disorders. This includes pathobiology of tissues and organs and the role of repair and regeneration, stem cell and cloning technology in therapeutics, the use of physical devices in repair and regeneration, solid organ and bone marrow transplantation, good manufacture practice (GMP), principles governing therapeutic goods administration and ethical problems in biotherapeutics. Outcomes: Students acquire an understanding of (1) the processes and mechanisms of tissue and organ regeneration and repair; (2) how this information can be used to devise therapeutic strategies including organ transplantation, cell therapy and gene therapy; and (3) quality assurance systems and auditory processes for therapeutic goods. Assessments tied to outcomes: Practical reports: L01, LO2, LO3 Seminars:LO3 Mid semester class test: LO1 Oral examination: LO3 Final written examination (LO1, LO2, LO3). 4/06/2012 Offerings Unit offered/shared in courses Credit points: 6 Assessment items: This includes practical reports, two seminars, a class test, an oral examination and a final examination containing essay questions. Reason for quota: Quota: Yes, proposed quota: 40 First year of offer: Approved: Workload hours per 6 pts: 150 Broadening categories: Not broadening category B: INFRASTRUCTRE RESTRICTIONS (EG: SPACE) Elective Location Mode Teaching Period Crawley Semester 2, 2013 face to face Unit role Title Sequence status Type Option Pathology and Laboratory Medicine Approved sequence Major Option Biomedical Science Approved sequence Major 26/04/2013 11:44:16 AM Pg. 1 of 2 1 Attachment G1

TRIM: PATH3311 Biotherapeutics and Regenerative Medicine ... · PATH3311 Biotherapeutics and Regenerative Medicine TRIM: F31940 ... cell therapy and gene therapy; ... the mechanisms

  • Upload
    habao

  • View
    220

  • Download
    0

Embed Size (px)

Citation preview

Page 1: TRIM: PATH3311 Biotherapeutics and Regenerative Medicine ... · PATH3311 Biotherapeutics and Regenerative Medicine TRIM: F31940 ... cell therapy and gene therapy; ... the mechanisms

PATH3311 Biotherapeutics and Regenerative Medicine

TRIM: F31940Unit ID: 975

Active Unit:

Unit Information

Resp. Org. Entity: Pathology and Laboratory Medicine (00830)

Level: 3

2012

Title: Biotherapeutics and Regenerative Medicine

Type: Undergraduate in major(s);

Faculty: Medicine, Dentistry and Health Sciences

Prerequisites: PATH3303 Advanced Pathology and Laboratory Medicine OR Biomedical Science major level 2 units

Corequisites: PATH3354 Immunology and Immunopathology is recommended

Incompatibilities: Nil.

Unit rules

Academic informationUnit Content: This unit provides an understanding of biological processes and mechanisms during regeneration and

repair and concepts of how they can be used and manipulated for the development of therapeutic strategies in a range of human disorders. This includes pathobiology of tissues and organs and the role of repair and regeneration, stem cell and cloning technology in therapeutics, the use of physical devices in repair and regeneration, solid organ and bone marrow transplantation, good manufacture practice (GMP), principles governing therapeutic goods administration and ethical problems in biotherapeutics.

Outcomes: Students acquire an understanding of (1) the processes and mechanisms of tissue and organ regeneration and repair; (2) how this information can be used to devise therapeutic strategies including organ transplantation, cell therapy and gene therapy; and (3) quality assurance systems and auditory processes for therapeutic goods.

Assessments tied to outcomes:

Practical reports: L01, LO2, LO3Seminars:LO3 Mid semester class test: LO1Oral examination: LO3 Final written examination (LO1, LO2, LO3).

4/06/2012

Offerings

Unit offered/shared in courses

Credit points: 6

Assessment items: This includes practical reports, two seminars, a class test, an oral examination and a final examination containing essay questions.

Reason for quota:

Quota: Yes, proposed quota: 40

First year of offer:

Approved:

Workload hours per 6 pts: 150

Broadening categories:

Not broadening category B: INFRASTRUCTRE RESTRICTIONS (EG: SPACE)

Elective

Location ModeTeaching PeriodCrawleySemester 2, 2013 face to face

Unit roleTitle Sequence status TypeOptionPathology and Laboratory Medicine Approved sequenceMajor

OptionBiomedical Science Approved sequenceMajor

26/04/2013 11:44:16 AMPg. 1 of 2

1

Attachment G1

Page 2: TRIM: PATH3311 Biotherapeutics and Regenerative Medicine ... · PATH3311 Biotherapeutics and Regenerative Medicine TRIM: F31940 ... cell therapy and gene therapy; ... the mechanisms

Teaching Responsibilities

Committee endorsements and approvals

Teaching Org % SummaryPathology and Laboratory Medicine100%

StatusReview committee Resolution Date NotesEndorsedFaculty Unknown. Imported from spreadsheet. Details

unknown.

EndorsedBoard of Studies (BSc) R25/11 Imported from spreadsheet. Details unknown.

EndorsedBoard of Coursework Studies R2/11 Imported from spreadsheet. Further details unknown.

ApprovedAcademic Council R15/11 Imported from spreadsheet. Further details unknown.

26/04/2013 11:44:16 AMPg. 2 of 2

2

Attachment G2

Page 3: TRIM: PATH3311 Biotherapeutics and Regenerative Medicine ... · PATH3311 Biotherapeutics and Regenerative Medicine TRIM: F31940 ... cell therapy and gene therapy; ... the mechanisms

PATH3354 Immunology and Immunopathology

TRIM: F31587Unit ID: 442

Active Unit:

Unit Information

Resp. Org. Entity: Pathology and Laboratory Medicine (00830)

Level: 3

2012

Title: Immunology and Immunopathology

Type: Undergraduate in major(s);

Faculty: Medicine, Dentistry and Health Sciences

Prerequisites: MICR2209 Introduction to Infectious Diseases and Immunology

Corequisites: PATH3311 Biotherapeutics and Regenerative Medicine is recommended

Incompatibilities: Nil.

students who have not completed the following units should discuss preliminary reading with the unit coordinator: ANHB2214 Human Organs and Systems, (BIOC2201 Biochemistry of the Cell or BIOC2202 Biochemical Regulation of Cell Function), (MICR2203 Introductory Microbiology or MICR2206 Epidemiology and Infection or PATH2201 Introduction to Human Disease)

Unit rules

Academic informationUnit Content: This unit includes lectures on haemopoiesis (how cells of the immune system develop and differentiate),

T-cells and cytokines (how the immune system is regulated) and autoreactivity (immune responses to self proteins) in health and disease. Students are taught by physicians involved in the diagnosis and treatment of these conditions, and by scientists engaged in research into disease pathogenesis. The unit is suitable for students interested in a career in clinical diagnostic laboratories or biomedical research.

Outcomes: Students acquire a sound knowledge of the fundamentals of immunology and an appreciation of how this has an impact on clinical and laboratory medicine.

Assessments tied to outcomes:

Laboratory reports will assess understanding of the principles and mastery of basic techniques. The class test will assess undertanding of the principles of Immunology. The final exam will assess how these influence tunours, and immunopathogenic and infectious disease.

13/02/2013

Teaching Responsibilities

Offerings

Unit offered/shared in courses

Advisable Prior Study:

Credit points: 6

Assessment items: This consists of a small number of laboratory classes, a class test midway through the unit to assess progress and a final three-hour examination.

Reason for quota:

Quota: Yes, proposed quota: 16

First year of offer:

Approved:

Workload hours per 6 pts: 150

Broadening categories:

Not broadening category B: INFRASTRUCTRE RESTRICTIONS (EG: SPACE)

Elective

Location ModeTeaching PeriodCrawleySemester 2, 2013 face to face

Unit roleTitle Sequence status TypeOptionPathology and Laboratory Medicine Approved sequenceMajor

OptionBiomedical Science Approved sequenceMajor

26/04/2013 11:44:24 AMPg. 1 of 2

3

Attachment G3

Page 4: TRIM: PATH3311 Biotherapeutics and Regenerative Medicine ... · PATH3311 Biotherapeutics and Regenerative Medicine TRIM: F31940 ... cell therapy and gene therapy; ... the mechanisms

Committee endorsements and approvals

Teaching Org % SummaryPathology and Laboratory Medicine100%

StatusReview committee Resolution Date NotesEndorsedFaculty Unknown. Imported from spreadsheet. Details

unknown.

EndorsedBoard of Studies (BSc) R25/11 Imported from spreadsheet. Details unknown.

EndorsedBoard of Coursework Studies R2/11 Imported from spreadsheet. Further details unknown.

ApprovedAcademic Council R15/11 Imported from spreadsheet. Further details unknown.

26/04/2013 11:44:24 AMPg. 2 of 2

4

Attachment G4

Page 5: TRIM: PATH3311 Biotherapeutics and Regenerative Medicine ... · PATH3311 Biotherapeutics and Regenerative Medicine TRIM: F31940 ... cell therapy and gene therapy; ... the mechanisms

ID: 402 | TRIM: F31563

Changes for 2014: PATH3303 Advanced Pathology and Laboratory Medicine I

Curriculum MJD-BIOMS Biomedical Science (BSc) as core in specialisation MJD-PLMED Pathology and Laboratory Medicine (BSc) as core

Level 3

Credit points 6

Outcomes Students are able to (1) achieve a sound knowledgeunderstand the molecular basis of the fundamentalsinduction of immunology and an appreciation of how this has an impact on clinical and laboratory medicineprotective immune responses; (2) achieve an understanding of the use of diagnostic anatomical pathology in diagnosis and managementunderstand the role of genetic factors in the causation of disease; (3) develop methodological laboratory skills in immunology and pathology; (understand the role of molecular testing in diagnosis of disease; (4) develop skillsdemonstrate a wide range of techniques used to detect and monitor disease in analysis and interpretation of scientific data; patients; and (5) developdemonstrate skills in analysissynthesis, critique and presentation of selected topicsclinical and laboratory data.

Endorsed by FMDHS faculty - R23/13, 16/04/2013

Justification provided:

PATH3311 Biotherapeutics and Regenerative Medicine and PATH3354 Immunology and Immunopathology removed from major sequence. This change reduces the number of units available in Pathology and Laboratory Medicine from 6 (2 core plus 4 options) to 4 (all core) units. We found with the options units that we had quite a lot of "essential content" being duplicated across units in order to ensure that every student had an adequate understanding. By making this content core, we will reduce duplication across units and the overall content lost from the major is minimal.

Content This unit includes lecturesfocuses on haemopoiesis (how cells of the immune system developdetailed molecular and differentiate), T-cellsbiochemical basis of human diseases, the mechanisms which an organism may defend itself against infections and cytokines (how the immune system is regulated)environmental insults and autoreactivity (immune responses to self proteins)the ways in health and disease.which this can be assessed through laboratory tests. Students are taught by physicians medical practitioners involved in the diagnosis and treatment of these conditions, and by physicians and scientists engaged in research into disease pathogenesis. The unit is suitable for students interested in a career in clinical diagnostic laboratories or biomedical research.

Endorsed by FMDHS faculty - R23/13, 16/04/2013

Justification provided:

PATH3311 Biotherapeutics and Regenerative Medicine and PATH3354 Immunology and Immunopathology removed from major sequence. This change reduces the number of units available in Pathology and Laboratory Medicine from 6 (2 core plus 4 options) to 4 (all core) units. We found with the options units that we had quite a lot of "essential content" being duplicated across units in order to ensure that every student had an adequate understanding. By making this content core, we will reduce duplication across units and the overall content lost from the major is minimal.

Impact:

This change has been discussed with the Sub-Dean of the Faculty of Science, the

5

Attachment G5

Page 6: TRIM: PATH3311 Biotherapeutics and Regenerative Medicine ... · PATH3311 Biotherapeutics and Regenerative Medicine TRIM: F31940 ... cell therapy and gene therapy; ... the mechanisms

Head of School of Pathology and Laboratory Medicine, and representatives from the Pathology and Laboratory Medicine and Biomedical Science undergraduate majors. They foresee no adverse impact on students studying these areas.

Assessments tied to outcomes

WrittenThe assessments will comprise a written examination (Outcomes 1LO1, 2 and 3)

Practical Reports (Outcomes 3), practical reports (LO4) and 4)

Assignments (Outcome 5)assignments (LO5).

Endorsed by FMDHS faculty - R23/13, 16/04/2013

No justification or notes provided.

Assessment items The assessment will include This comprises practical reports (25 per cent); assignments (25 per cent); and a two-hour end-of-semester written examination and mid-semester test and practical class reports.(50 per cent).

Endorsed by FMDHS faculty - R21/13, 16/04/2013

No justification or notes provided.

Prerequisites Completion of Level 2 of a Major in Pathology and Laboratory Medicine or Biomedical Science; for pre-2012 courses: MICR2204 Introductory Microbiology.PATH2220 Introduction to Human Disease

Endorsed by FMDHS faculty - R23/13, 16/04/2013

Justification provided:

Prerequisites and advisable prior study made consistent across all Level 3 units.

Corequisites Nil.

Incompatibilities Nil.

Availabilities 2014 Semester 1, Crawley, face to face [new]Not available in 2013

Endorsed by FMDHS faculty - R23/13, 16/04/2013

No justification or notes provided.

Is broadening category A? False

Is broadening category B? False

6

Attachment G6

Page 7: TRIM: PATH3311 Biotherapeutics and Regenerative Medicine ... · PATH3311 Biotherapeutics and Regenerative Medicine TRIM: F31940 ... cell therapy and gene therapy; ... the mechanisms

ID: 435 | TRIM: F31582

Changes for 2014: PATH3306 Integrated and Applied Pathology and Laboratory Medicine II

Curriculum MJD-BIOMS Biomedical Science (BSc) as core in specialisation MJD-PLMED Pathology and Laboratory Medicine (BSc) as core

Level 3

Credit points 6

Outcomes Students acquire an understanding of are able to (1) the processesunderstand and mechanisms of tissuedescribe the investigation of human diseases, specifically clinical presentation and organ disease, regeneration and repair; (2) how this information can be used to devise therapeutic strategiesdetailed pathogenesis including organ transplantation, cell therapythe genetic basis of susceptibility, treatment and complications; and gene therapy;(2) demonstrate skills in synthesis, critique and (3) quality assurance systemspresentation of clinical and auditory processes for therapeutic goodslaboratory data.

Endorsed by FMDHS faculty - R23/13, 16/04/2013

Justification provided:

PATH3311 Biotherapeutics and Regenerative Medicine and PATH3354 Immunology and Immunopathology removed from major sequence. This change reduces the number of units available in Pathology and Laboratory Medicine from 6 (2 core plus 4 options) to 4 (all core) units. We found with the options units that we had quite a lot of "essential content" being duplicated across units in order to ensure that every student had an adequate understanding. By making this content core, we will reduce duplication across units and the overall content lost from the major is minimal.

Impact:

This change has been discussed with the Sub-Dean of the Faculty of Science, the Head of School of Pathology and Laboratory Medicine, and representatives from the Pathology and Laboratory Medicine and Biomedical Science undergraduate majors. They foresee no adverse impact on students studying these areas.

Content This unit focuses on complex problems relating to human disease. Students are taught by medical practitioners involved in the diagnosis and treatment of these conditions, and by physician/scientists and scientists engaged in research into disease pathogenesis. The unit includes practical sessions that demonstrate multidisiplinary approaches to research questions and laboratory diagnostic scenarios in areas releted to current work performed in Perth. Students apply scientific knowledge and techniques, and engage in scientific problem-solving. The unit is suitable for students interested in a career in clinical diagnostic laboratories or biomedical research.

Assessments tied to outcomes

Assessment will include assignments and case reports, plus a final exam designed to assess the students understanding of the fundamentals of disease

Assessment items This comprises assignments (25 per cent); case reports (25 per cent); and a three-hour end-of-semester written examination (50 per cent).

Prerequisites Completion of Level 2 of a Major inPATH3303 Advanced Pathology and Laboratory Medicine orOR Biomedical Science major level 2 units

7

Attachment G7

Page 8: TRIM: PATH3311 Biotherapeutics and Regenerative Medicine ... · PATH3311 Biotherapeutics and Regenerative Medicine TRIM: F31940 ... cell therapy and gene therapy; ... the mechanisms

Endorsed by FMDHS faculty - R23/13, 16/04/2013

Justification provided:

Prerequisites and advisable prior study made consistent across all Level 3 units.

Corequisites Nil.

Incompatibilities Nil.

Availabilities 2014 Semester 2, Crawley, face to face [new]Not available in 2013

Endorsed by FMDHS faculty - R23/13, 16/04/2013

Justification provided:

Unit made available for the first time in 2014.

Is broadening category A? False

Is broadening category B? False

8

Attachment G8

Page 9: TRIM: PATH3311 Biotherapeutics and Regenerative Medicine ... · PATH3311 Biotherapeutics and Regenerative Medicine TRIM: F31940 ... cell therapy and gene therapy; ... the mechanisms

ID: 403 | TRIM: F31564

Changes for 2014: PATH3302 Cancer Pathology: Human Oncobiology

Curriculum MJD-BIOMS Biomedical Science (BSc) as core in specialisation [Active] MJD-PLMED Pathology and Laboratory Medicine (BSc) as core [Active]

Level 3

Credit points 612

Endorsed by FMDHS faculty - R23/13, 16/04/2013

Impact:

Contact hours, outcomes and assessment have been reduced to suit a 6 point unit.

Outcomes Students achieve (1) an understanding of the cellular and molecular mechanisms involved in the genetic predisposition, development and progression of neoplasia in humans; (2) an understanding of the role of modifications to oncogenes and tumour suppressor genes in abnormal cell growth as well as factors which influence programmed cell death and mechanisms implicated in tumour angiogenesis, invasion and metastasis; (3) an understanding of the pathobiology of the major types of human cancers including those which occur in the breast, colon and prostate; (4) an understanding of the strategies and possible outcomes of different types of therapies applicable to different types of cancer; (5) laboratory skills through practical sessions which are designed to expose students to a wide range of techniques and methods used to investigate and demonstrate cellular and genetic changes associated with the development of human tumours; (6) a greater depth of knowledge in a specific area of cancer biology through the completion of a basic research project; and (7) skills in synthesis, critique and oral presentation of scientific literature.

Endorsed by FMDHS faculty - R23/13, 16/04/2013

Justification provided:

Outcomes and assessment have been reduced to suit a 6 point unit.

Content This unit offers an advanced study in cellular and molecular changes responsible for the development and progression of human cancers. Special emphasis is given to the role of oncogenes and tumour suppressor genes in abnormal cell growth, programmed cell death, as well as mechanisms of tumour angiogenesis, invasion, metastasis and response to therapy. Several major types of human cancers are covered including those of the breast, colon and prostate. Hereditary cancer syndromes are also discussed. Practical aspects of the unit include techniques for investigation into the cellular and genetic changes occurring in human tumours.

Assessments tied to outcomes

The assessment will include a written examination and mid-semester test (LO1 - 4), practical classes and report (LO5-6) and a student seminar (LO6-7).

Endorsed by FMDHS faculty - R23/13, 16/04/2013

Justification provided:

Outcomes and assessment have been reduced to suit a 6 point unit.

Assessment items This comprisesincludes practical reports (25 per cent); assignments (25 per cent);, a research project report, two class presentations and a two-hour end-ofshort mid-semester test. Final examinations consist of a three-hour written and a short oral

9

Attachment G9

Page 10: TRIM: PATH3311 Biotherapeutics and Regenerative Medicine ... · PATH3311 Biotherapeutics and Regenerative Medicine TRIM: F31940 ... cell therapy and gene therapy; ... the mechanisms

examination (50 per cent)..

Endorsed by FMDHS faculty - R23/13, 16/04/2013

No justification or notes provided.

Prerequisites Completion of Level 2 of a Major inPATH3303 Advanced Pathology and Laboratory Medicine or Biomedical Science; (; for pre-2012 courses: 12 points from ANHB2214 Human Organs and Systems, BIOC2201 Biochemistry of the Cell, BIOC2202BIOC2002 Biochemical Regulation of Cell Function, GENE3330 Molecular Genetics and Genomics, MICR2203 Introductory Immunology, MICR2204 Introductory Microbiology, MICR2206 Epidemiology and Infection, PATH2201PATH2220 Introduction to Human Disease)

Endorsed by FMDHS faculty - R23/13, 16/04/2013

Justification provided:

Prerequisites and advisable prior study made consistent across all Level 3 units.

Corequisites Nil.

Incompatibilities Nil.

Availabilities Semester 2 2013, Crawley, face to face

Is broadening category A? False

Is broadening category B? False

10

Attachment G10

Page 11: TRIM: PATH3311 Biotherapeutics and Regenerative Medicine ... · PATH3311 Biotherapeutics and Regenerative Medicine TRIM: F31940 ... cell therapy and gene therapy; ... the mechanisms

Pathology and Laboratory Medicine (MJD-PLMED) - approved unit sequence TRIM: F29732ID: 146

TypeCode Title Unit rulesTRIM Pts Approval

Level 1Take core units:

CHEM1004 Biological Chemistry Prerequisites: WACE Chemistry 3A/3B OR TEE Chemistry OR CHEM1003 Introductory Chemistry OR equivalent

F32101 6Core Approved by Academic Council - R160/10

SCIE1106 Molecular Biology of the Cell Prerequisites: BIOL1130 Frontiers in Biology (formerly BIOL1130 Core Concepts in Biology) or ANHB1101 Human Biology I: Becoming Human or (WACE Biology 3A/3B or WACE Human Biology 3A/3B) or (TEE Biology or TEE Human Biology); WACE Chemistry 3A/B or TEE Chemistry or a Level 1 chemistry unit. Students who have not completed BIOL1130 or ANHB1101 are advised to contact the unit coordinator.Incompatibilities: SCIE2225 Molecular Biology passed in or before 2004

F31971 6Core Approved by Academic Council - R73/11

Take complementary units:BIOL1130 Frontiers in BiologyF32142 6Complementary Approved by Academic

Council - R73/11

CHEM1003 Introductory Chemistry Incompatibilities: This unit is not available to students who have a satisfactory performance (scaled score of 50 per cent or more) in WACE Chemistry 3A/3B or TEE Chemistry, or equivalent.

F32003 6Complementary Approved by Academic Council - R160/10

Level 2Take core units:

PATH2210 Fundamentals of Pathology and Laboratory MedicineF31581 6Core Approved by Academic Council - Unknown.

PATH2220 Introduction to Human DiseaseF31515 6Core Approved by Academic Council - R15/11

Take complementary units:BIOC2203 Biochemistry and Molecular Biology of the Cell Prerequisites: SCIE1106 Molecular Biology of the Cell and one of (CHEM1004

Biological Chemistry or CHEM1002 Chemistry—Structure and Reactivity)Incompatibilities: BIOC2201 Biochemistry of the Cell, SCIE2225 Molecular Biology

F32112 6Complementary Approved by Academic Council - R15/11

MICR2209 Introduction to Infectious Diseases and Immunology Prerequisites: SCIE1106 Molecular Biology of the Cell AND (BIOL1130 Core Concepts in Biology OR ANHB1101 Human Biology I: Becoming Human OR ANHB1102 Human Biology II: Being Human)Incompatibilities: For pre-2012 courses: MICR2205 General and Applied Microbiology

F31764 6Complementary Approved by Academic Council - R73/11

Page 1 of 2Current as at Wednesday, 1 May 2013 CONTINUED ON NEXT PAGE

11

Attachment G11

Page 12: TRIM: PATH3311 Biotherapeutics and Regenerative Medicine ... · PATH3311 Biotherapeutics and Regenerative Medicine TRIM: F31940 ... cell therapy and gene therapy; ... the mechanisms

TypeCode Title Unit rulesTRIM Pts Approval

Level 3Take core units:

PATH3303 Advanced Pathology and Laboratory Medicine Prerequisites: PATH2220 Introduction to Human DiseaseF31563 6Core Approved by Academic Council - R15/11

PATH3306 Integrated and Applied Pathology Prerequisites: PATH3303 Advanced Pathology and Laboratory Medicine OR Biomedical Science major level 2 units

F31582 6Core Approved by Academic Council - R15/11

Take 2 options from this group (A):PATH3302 Pathology: Human Oncobiology Prerequisites: PATH3303 Advanced Pathology and Laboratory Medicine; for pre-2012

courses: 12 points from ANHB2214 Human Organs and Systems, BIOC2201 Biochemistry of the Cell, BIOC2202 Biochemical Regulation of Cell Function, GENE3330 Molecular Genetics and Genomics, MICR2203 Introductory Immunology, MICR2204 Introductory Microbiology, MICR2206 Epidemiology and Infection, PATH2220 Introduction to Human Disease

F31564 12Option (A) (12 points)

Approved by Academic Council - R15/11

PATH3305 Medical Genetics Prerequisites: PATH3303 Advanced Pathology and Laboratory Medicine or (GENE2230 Molecular Genetics I and GENE2250 Principles of Inheritance)

F31927 6Option (A) Approved by Academic Council - R15/11

PATH3311 Biotherapeutics and Regenerative Medicine Prerequisites: PATH3303 Advanced Pathology and Laboratory Medicine OR Biomedical Science major level 2 unitsCorequisites: PATH3354 Immunology and Immunopathology is recommended

F31940 6Option (A) Approved by Academic Council - R15/11

PATH3354 Immunology and Immunopathology Prerequisites: MICR2209 Introduction to Infectious Diseases and ImmunologyCorequisites: PATH3311 Biotherapeutics and Regenerative Medicine is recommended

F31587 6Option (A) Approved by Academic Council - R15/11

Page 2 of 2Current as at Wednesday, 1 May 2013

12

Attachment G12

Page 13: TRIM: PATH3311 Biotherapeutics and Regenerative Medicine ... · PATH3311 Biotherapeutics and Regenerative Medicine TRIM: F31940 ... cell therapy and gene therapy; ... the mechanisms

Pathology and Laboratory Medicine (MJD-PLMED) - proposed new unit sequence TRIM: F29732ID: 146

TypeCode Title Unit rulesTRIM Pts Approval

Level 1Take core units:

CHEM1004 Biological Chemistry Prerequisites: WACE Chemistry 3A/3B OR TEE Chemistry OR CHEM1003 Introductory Chemistry OR equivalent

F32101 6Core Approved by Academic Council - R160/10

SCIE1106 Molecular Biology of the Cell Prerequisites: BIOL1130 Frontiers in Biology (formerly BIOL1130 Core Concepts in Biology) or ANHB1101 Human Biology I: Becoming Human or (WACE Biology 3A/3B or WACE Human Biology 3A/3B) or (TEE Biology or TEE Human Biology); WACE Chemistry 3A/B or TEE Chemistry or a Level 1 chemistry unit. Students who have not completed BIOL1130 or ANHB1101 are advised to contact the unit coordinator.Incompatibilities: SCIE2225 Molecular Biology passed in or before 2004

F31971 6Core Approved by Academic Council - R73/11

Take complementary units:BIOL1130 Frontiers in BiologyF32142 6Complementary Approved by Academic

Council - R73/11

CHEM1003 Introductory Chemistry Incompatibilities: This unit is not available to students who have a satisfactory performance (scaled score of 50 per cent or more) in WACE Chemistry 3A/3B or TEE Chemistry, or equivalent.

F32003 6Complementary (Not available to students who have a satisfactory performance (scaled score of 50 per cent or more) in WACE Chemistry 3A/3B or TEE Chemistry, or equivalent. These students are exempted from the requirement to take this unit as a complementary unit for the MJD-PLMED.)

Approved by Academic Council - R160/10

Page 1 of 2Current as at Wednesday, 1 May 2013 CONTINUED ON NEXT PAGE

13

Attachment G13

Page 14: TRIM: PATH3311 Biotherapeutics and Regenerative Medicine ... · PATH3311 Biotherapeutics and Regenerative Medicine TRIM: F31940 ... cell therapy and gene therapy; ... the mechanisms

TypeCode Title Unit rulesTRIM Pts Approval

Level 2Take core units:

PATH2210 Fundamentals of Pathology and Laboratory MedicineF31581 6Core Approved by Academic Council - Unknown.

PATH2220 Introduction to Human DiseaseF31515 6Core Approved by Academic Council - R15/11

Take complementary units:BIOC2203 Biochemistry and Molecular Biology of the Cell Prerequisites: SCIE1106 Molecular Biology of the Cell and one of (CHEM1004

Biological Chemistry or CHEM1002 Chemistry—Structure and Reactivity)Incompatibilities: BIOC2201 Biochemistry of the Cell, SCIE2225 Molecular Biology

F32112 6Complementary Approved by Academic Council - R15/11

MICR2209 Introduction to Infectious Diseases and Immunology Prerequisites: SCIE1106 Molecular Biology of the Cell AND (BIOL1130 Core Concepts in Biology OR ANHB1101 Human Biology I: Becoming Human OR ANHB1102 Human Biology II: Being Human)Incompatibilities: For pre-2012 courses: MICR2205 General and Applied Microbiology

F31764 6Complementary Approved by Academic Council - R73/11

Level 3Take core units:

PATH3302 Pathology: Human Oncobiology(new title will be:Cancer Pathology)

Prerequisites: PATH3303 Advanced Pathology and Laboratory Medicine; for pre-2012 courses: 12 points from ANHB2214 Human Organs and Systems, BIOC2201 Biochemistry of the Cell, BIOC2202 Biochemical Regulation of Cell Function, GENE3330 Molecular Genetics and Genomics, MICR2203 Introductory Immunology, MICR2204 Introductory Microbiology, MICR2206 Epidemiology and Infection, PATH2220 Introduction to Human Disease

F31564 12 (6)

Core (12 points,proposed change to 6)

Approved by Academic Council - R15/11

PATH3303 Advanced Pathology and Laboratory Medicine(new title will be:Pathology and Laboratory Medicine I)

Prerequisites: PATH2220 Introduction to Human DiseaseF31563 6Core Approved by Academic Council - R15/11

PATH3305 Medical Genetics Prerequisites: PATH3303 Advanced Pathology and Laboratory Medicine or (GENE2230 Molecular Genetics I and GENE2250 Principles of Inheritance)

F31927 6Core Approved by Academic Council - R15/11

PATH3306 Integrated and Applied Pathology(new title will be:Pathology and Laboratory Medicine II)

Prerequisites: PATH3303 Advanced Pathology and Laboratory Medicine OR Biomedical Science major level 2 units

F31582 6Core Approved by Academic Council - R15/11

Page 2 of 2Current as at Wednesday, 1 May 2013

14

Attachment G14

kwilliams
Highlight
kwilliams
Highlight
kwilliams
Highlight
kwilliams
Highlight